Clinical trials for Cancer in United States

Shortened Course Adjuvant Radiotherapy Following TORS

Study ID: NCT05714657

Sponsor

Abramson Cancer Center at Penn Medicine

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

Study ID: NCT04768426

Sponsor

Stanford University

Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

Study ID: NCT06130826

Sponsor

City of Hope Medical Center

Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma

Study ID: NCT02203526

Sponsor

National Cancer Institute (NCI)

A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

Study ID: NCT06146257

Sponsor

GluBio Therapeutics Inc.

Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients

Study ID: NCT06909357

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Investigations of Reproductive Cancers in Women

Study ID: NCT06527157

Sponsor

PinkDx, Inc.

Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy

Study ID: NCT06542757

Sponsor

NYU Langone Health

Training in Evidence-based Treatments in Psycho-Oncology

Study ID: NCT05674357

Sponsor

Massachusetts General Hospital

Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection

Study ID: NCT02910557

Sponsor

Amgen